Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The company has built the world's largest library of clinical and molecular data and an operating system to make that data accessible and useful.

Tempus provides genomic sequencing and data analysis for oncology and other diseases, helping physicians make real-time, data-driven decisions for cancer patients. The company went public in 2024 and serves major healthcare institutions with AI-powered diagnostic and therapeutic insights.